Read more
3:59 PM · 2 August 2023

DE30: US credit rating downgrade pushes European indices down

Hugo Boss
Stocks
BOSS.DE, HUGO BOSS AG
-
-
BAE
Stocks
BA.UK, BAE Systems PLC
-
-
Siemens Health
Stocks
SHL.DE, Siemens Healthineers AG
-
-
  • Investor attention turns to ADP report

  • Earnings from Hugo Boss (BOSS.DE) and BAE Systems (BA.UK) 

Wednesday's session on European markets began with steep declines following the decision by credit rating agency Fitch to downgrade the US credit rating. Following the news, stock indices posted sizable declines, but these are now largely erased. 

Investors' attention today is focused on the ADP data reading from the US, which will be an important indication ahead of Friday's NFP report (the key macroeconomic report for the US economy). 

The mood in Europe during Wednesday's trading session is clearly negative, extending the downward momentum that began yesterday. Source: xStation 5

German DE30 futures are losing nearly 0.9% during today's session. However, it is worth noting that most of the declines recorded since the start of the session have already been negated. Source: xStation 5

News:

BNPP Exane raised its recommendation on shares of Siltronic (WAF.DE) to an "outperform" rating. The target price was set at EUR 98. The company's shares are currently gaining close to 1.75%. 

Siltronic (WAF.DE) share price, W1 interval. Source: xStation 5

Against the backdrop of a broad market sell-off in Europe, the company which managed to post a sizable gain was the BAE Systems (BA.UK). The company raised its earnings forecasts for the year on the back of massive defence spending

The company now expects full year EPS to be 10%-12% higher, the previous forecast of 5%-7%.

The company has approved a further share buyback of up to £1.5 billion.

BAE Systems (BA.UK) share price, D1 interval. Source: xStation 5

On the other hand, one of the worst performing companies at the moment is Siemens Healthineers (SHL.DE), which is losing more than 6% in the face of worse-than-expected quarterly results. On the other hand, however, the company confirmed its earnings forecasts for the year. 

Siemens Healthineers (SHL.DE) share price, D1 interval. Source: xStation 5

Fashion companies are reacting today to the results of Hugo Boss (BOSS.DE), which turned out to be very good for the company itself, nevertheless some uncertainty factors were undermined. The company raised its profit and sales forecast for 2023 (sales are expected to grow by 12%-15% against an earlier forecast of 10%,and operating profit to €400-420 million against the previously expected €370-400 million).  However, shares lost ground during today's session against higher stocks (up 53% in the first half of the year).

Hugo Boss (BOSS.DE) share price, W1 interval. Source: xStation 5

Largest percentage change in individual DAX index companies. Source: Bloomberg Finance L.P.

Information from individual companies in the DAX index. Source: Bloomberg Finance L.P.

 

5 November 2025, 7:43 PM

US OPEN: Is This the Turning Point After the Correction?

5 November 2025, 7:00 PM

BREAKING: Service ISM clearly higher than expected. US500 continues rebound

5 November 2025, 6:46 PM

McDonald's shares rise 3% after reporting its third quarter 2025 results

5 November 2025, 3:02 PM

Arista Networks drops 12% despite solid earnings📉Guidance triggered profit-taking on Wall Street

The material on this page does not constitute as financial advice and does not take into account your level of understanding, investment objectives, financial situation or any other particular needs.
All the information provided, including opinions, market research, mathematical results and technical analyses published on the website or transmitted to you by other means is provided for information purposes only and should in no event be interpreted as an offer of, or solicitation for, a transaction in any financial instrument, nor should the information provided be construed as advice of legal or fiscal nature.
Any investment decisions you make shall be based exclusively on your level of understanding, investment objectives, financial situation or any other particular needs. Any decision to act on information published on the website or transmitted to you by other means is entirely at your own risk. You are solely responsible for such decisions.
If you are in doubt or are not sure that you understand a particular product, instrument, service, or transaction, you should seek professional or legal advice before trading.
Investing in OTC Derivatives carries a high degree of risk, as they are leveraged based products and often small movements in the market could lead to much larger movements in the value of your investment and this could work against you or for you. Please ensure that you fully understand the risks involved, taking into account your investments objectives and level of experience, before trading, and if necessary, seek independent advice.

Join over 2 000 000 investors from around the world